On November 1, 2023 Affimed N.V. (Nasdaq: AFMD) ("Affimed" or the "Company"), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported that the Company’s management will participate in the following investor conferences during the month of November 2023 (Press release, Affimed, NOV 1, 2023, View Source [SID1234636669]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Truist Securities BioPharma Symposium (November 8-9, 2023)
Date: Wednesday, November 8, 2023
One-on-one meetings only Location: New York, NY
Jefferies London Healthcare Conference (November 14-16, 2023)
Date: Wednesday, November 15, 2023
Presentation Time: 8:30 a.m. EST / 1:30 p.m. GMT / 14:30 CET. Location: London, UK
Webcast: View Source
For more information or to schedule a one-on-one meeting with Affimed’s management, please contact your event representative or Alex Fudukidis via email at [email protected] or phone at +1 (917) 436-8102.